Perioperative Glucose Monitoring and Treatment to Reduce Risk of Surgical Site Infections and Complications

Summary

This study is to determine if glucose monitoring and treatment in surgical procedures over 2 hours help to decrease the surgical site infection risk and reduce postoperative complications. The study uses a preoperative HgBA1C to place patient into a sliding scale insulin category to be used only if the patient has a blood sugar over 150mg/dL during surgery. This is consistent with the CDC recommendation to keep perioperative glucose below 200 mg/dL in surgical patients. The protocol continues for at least 48 hours to treat stress hyperglycemia in non-diabetic patients, and to closely monitor \& treat glucose levels in diabetic patients.

Timeline

Start

2024-04-09

Primary completion

2025-01-31

Completion

2025-01-31

Drugs

Indications